SCHEMBL24373461

SCHEMBL24373461

N#Cc1c(Br)cc2c(c1Br)COCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29478826 1.00 — —
SCHEMBL24373453 0.76 ALDH1A1 (0.34) —
SCHEMBL29479151 0.76 ALDH1A1 (0.34) —
SCHEMBL29479180 0.75 — —
SCHEMBL24373489 0.75 MEN1 (0.32) —
SCHEMBL29479092 0.75 MEN1 (0.32) —
SCHEMBL27096420 0.75 — —
SCHEMBL34473900 0.69 IKBKB (0.36) —
SCHEMBL25296297 0.68 WNT3A (0.32) —
SCHEMBL30715963 0.68 WNT3A (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240059703-A1 HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE AMGEN INC. 2024-02-22 — — US disclosed
WO-2022083569-A1 HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2022-04-28 — — WO disclosed
Send feedback